Clinical Trial Update: Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing immunogenicity and safety of two influenza vaccine strategies in adults with severe/morbid obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Obesity

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Morbid Obesity, Severe Obesity | Phase 3 | Status: COMPLETED